Adrian Donnelly, PA
Physician Assistant · Tulsa, OKNPI 1164881199
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 557 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 557 payments — averaging $21.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Dexcom, Inc.$1K
- Lilly USA, LLC$1K
- Novo Nordisk$1K
- Boehringer Ingelheim$787
- Bayer$734
- plus $5K from 31 others
What the payments were for
- Food & beverage$11,868100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 55 | $1,688 |
| Dexcom, Inc. | 86 | $1,475 |
| Lilly USA, LLC | 56 | $1,216 |
| Novo Nordisk | 67 | $1,194 |
| Boehringer Ingelheim | 35 | $787 |
| Bayer | 33 | $734 |
| Esperion Therapeutics, Inc. | 20 | $614 |
| Insulet Corporation | 14 | $557 |
| Novartis | 26 | $454 |
| Mannkind Corporation | 19 | $360 |
| Amgen | 23 | $319 |
| Xeris Pharmaceuticals, Inc. | 14 | $268 |
| Tandem Diabetes Care, Inc. | 11 | $260 |
| Corcept Therapeutics | 15 | $250 |
| Amneal Pharmaceuticals LLC | 13 | $248 |
| AstraZeneca(2 entities) | 9 | $234 |
| AbbVie | 11 | $177 |
| Medtronic | 4 | $163 |
| Kyowa Kirin, Inc. | 5 | $110 |
| Currax Pharmaceuticals LLC | 7 | $102 |
| Johnson & Johnson | 2 | $101 |
| Antares Pharma, Inc. | 5 | $74 |
| Sanofi-aventis U.S. LLC | 4 | $62 |
| Astellas Pharma US Inc | 2 | $52 |
| Recordati_rare_diseases_inc. | 2 | $50 |
| Endo Pharmaceuticals Inc. | 3 | $47 |
| Boston Scientific | 2 | $42 |
| BETA Bionics, Inc. | 2 | $37 |
| Intra-sana Laboratories | 2 | $36 |
| Halozyme Inc | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Ascendis Pharma Endocrinology Inc | 1 | $24 |
| IBSA Pharma Inc. | 1 | $15 |
| Philips North America LLC | 1 | $15 |
| Merck | 1 | $13 |
| Siemens Medical Solutions USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$582
- JARDIANCE$336
- NEXLIZET$244
- NEXLETOL$244
- Wegovy$243
- DEXCOM G6 TRANSMITTER$220
- FreeStyle Libre$173
- RYBELSUS$118
- Saxenda$115
- AFREZZA$115
- MINIMED 780G$110
- Kerendia$109
- ZEPBOUND$109
- Omnipod$108
How this compares
$11,868 in reported general payments places this provider in the 95th percentile of 1,491 physician assistant providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 237 | $304,136 |
| OzempicSemaglutide | 127 | $226,568 |
| TrulicityDulaglutide | 101 | $138,073 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $74,398 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 58 | $72,987 |
| JardianceEmpagliflozin | 58 | $64,531 |
| Tresiba Flextouch U-200Insulin Degludec | 52 | $62,782 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 23 | $51,506 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 22 | $42,240 |
| FarxigaDapagliflozin Propanediol | 32 | $40,197 |
| Xigduo XrDapaglifloz Propaned/Metformin | 42 | $34,843 |
| ProliaDenosumab | 15 | $26,999 |
| VascepaIcosapent Ethyl | 36 | $25,037 |
| SynthroidLevothyroxine Sodium | 265 | $21,231 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 17 | $14,091 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $1,216 | $448,249355 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $1,194 | $244,585152 claims |
| Boehringer IngelheimSynjardy Xr, Jardiance | $787 | $137,518116 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $62 | $42,24022 claims |
| AstraZenecaFarxiga | $234 | $40,19732 claims |
| AmgenProlia | $319 | $26,99915 claims |
| AbbVieSynthroid | $177 | $21,231265 claims |
| MerckJanuvia | $13 | $13,68618 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $248 | $5,668613 claims |
| Esperion Therapeutics, Inc.Nexlizet | $614 | $5,09511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,491 physician assistant providers in Oklahoma.
Other physician assistant in Tulsa
- Matthew PattonTulsa$24K
- Michelle GreenTulsa$18K
- Muge ParkTulsa$17K
- Rose RamirezTulsa$15K
- Melissa RohrerTulsa$14K
- Jenny BirksTulsa$13K
- Andrea BellassaiTulsa$12K
- Jennifer ComptonTulsa$12K
- Valerie TerrellTulsa$12K
- Lori RuleTulsa$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.